260 related articles for article (PubMed ID: 32058173)
1. Worsening of anti-Hu paraneoplastic neurological syndrome related to anti-PD-1 treatment: Case report and review of literature.
Raibagkar P; Ho D; Gunturu KS; Srinivasan J
J Neuroimmunol; 2020 Apr; 341():577184. PubMed ID: 32058173
[TBL] [Abstract][Full Text] [Related]
2. A case series of PD-1 inhibitor-associated paraneoplastic neurologic syndromes.
Gill A; Perez MA; Perrone CM; Bae CJ; Pruitt AA; Lancaster E
J Neuroimmunol; 2019 Sep; 334():576980. PubMed ID: 31195181
[TBL] [Abstract][Full Text] [Related]
3. Anti-Hu antibodies may indicate a positive response to chemotherapy in paraneoplastic syndrome secondary to small cell lung cancer.
Douglas CA; Ellershaw J
Palliat Med; 2003 Oct; 17(7):638-9. PubMed ID: 14594156
[TBL] [Abstract][Full Text] [Related]
4. Value of Hu antibody determinations in the follow-up of paraneoplastic neurologic syndromes.
Lladó A; Mannucci P; Carpentier AF; Paris S; Blanco Y; Saiz A; Delattre JY; Graus F
Neurology; 2004 Nov; 63(10):1947-9. PubMed ID: 15557520
[TBL] [Abstract][Full Text] [Related]
5. Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors.
Vogrig A; Fouret M; Joubert B; Picard G; Rogemond V; Pinto AL; Muñiz-Castrillo S; Roger M; Raimbourg J; Dayen C; Grignou L; Pallix-Guyot M; Lannoy J; Ducray F; Desestret V; Psimaras D; Honnorat J
Neurol Neuroimmunol Neuroinflamm; 2019 Nov; 6(6):. PubMed ID: 31454760
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes.
Storstein A; Raspotnig M; Vitaliani R; Giometto B; Graus F; Grisold W; Honnorat J; Vedeler CA
J Neurol; 2016 May; 263(5):1001-1007. PubMed ID: 27007485
[TBL] [Abstract][Full Text] [Related]
7. [Small cell lung cancer associated with anti-Hu antibody-positive paraneoplastic neurologic syndrome].
Kuronuma K; Nishiyama K; Murakami S; Tanaka N; Takahashi M; Kojima H; Fujishima T; Tanaka H; Takahashi H; Koba H; Tanaka K; Abe S
Nihon Kokyuki Gakkai Zasshi; 2000 Feb; 38(2):148-52. PubMed ID: 10774176
[TBL] [Abstract][Full Text] [Related]
8. Profiling Preexisting Antibodies in Patients Treated With Anti-PD-1 Therapy for Advanced Non-Small Cell Lung Cancer.
Toi Y; Sugawara S; Sugisaka J; Ono H; Kawashima Y; Aiba T; Kawana S; Saito R; Aso M; Tsurumi K; Suzuki K; Shimizu H; Domeki Y; Terayama K; Nakamura A; Yamanda S; Kimura Y; Honda Y
JAMA Oncol; 2019 Mar; 5(3):376-383. PubMed ID: 30589930
[TBL] [Abstract][Full Text] [Related]
9. Anti-Hu-associated paraneoplastic encephalomyelitis with esophageal small cell carcinoma.
Shirafuji T; Kanda F; Sekiguchi K; Higuchi M; Yokozaki H; Tanaka K; Takahashi H; Toda T
Intern Med; 2012; 51(17):2423-7. PubMed ID: 22975561
[TBL] [Abstract][Full Text] [Related]
10. Nivolumab-induced Limbic Encephalitis with Anti-Hu Antibody in a Patient With Advanced Pleomorphic Carcinoma of the Lung.
Matsuoka H; Kimura H; Koba H; Tambo Y; Ohkura N; Hara J; Sone T; Kasahara K
Clin Lung Cancer; 2018 Sep; 19(5):e597-e599. PubMed ID: 29857970
[No Abstract] [Full Text] [Related]
11. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
[TBL] [Abstract][Full Text] [Related]
12. An autoimmune-based, paraneoplastic neurologic syndrome following checkpoint inhibition and concurrent radiotherapy for merkel cell carcinoma: case report.
Sherry AD; Bezzerides M; Khattab MH; Luo G; Ancell KK; Kirschner AN
Strahlenther Onkol; 2020 Jul; 196(7):664-670. PubMed ID: 32006066
[TBL] [Abstract][Full Text] [Related]
13. Anti-Hu-Associated Autoimmune Limbic Encephalitis in a Patient with PD-1 Inhibitor-Responsive Myxoid Chondrosarcoma.
Papadopoulos KP; Romero RS; Gonzalez G; Dix JE; Lowy I; Fury M
Oncologist; 2018 Jan; 23(1):118-120. PubMed ID: 29158368
[TBL] [Abstract][Full Text] [Related]
14. Toxicity management with combination chemotherapy and programmed death 1/programmed death ligand 1 inhibitor therapy in advanced lung cancer.
Hoffner B; Leighl NB; Davies M
Cancer Treat Rev; 2020 Apr; 85():101979. PubMed ID: 32078962
[TBL] [Abstract][Full Text] [Related]
15. Effect of PD-1 inhibitor on exhaled nitric oxide and pulmonary function in non-small cell lung cancer patients with and without COPD.
Suzuki Y; Inui N; Karayama M; Imokawa S; Yamada T; Yokomura K; Asada K; Kusagaya H; Kaida Y; Matsuda H; Koshimizu N; Toyoshima M; Masuda M; Hayakawa H; Hozumi H; Furuhashi K; Enomoto N; Fujisawa T; Nakamura Y; Suda T
Int J Chron Obstruct Pulmon Dis; 2019; 14():1867-1877. PubMed ID: 31686799
[TBL] [Abstract][Full Text] [Related]
16. Anti-Hu Antibody-associated Paraneoplastic Neurological Syndrome Showing Peripheral Neuropathy and Atypical Multifocal Brain Lesions.
Shibata M; Uchida M; Tsukagoshi S; Yamaguchi K; Yamaguchi A; Furuta N; Makioka K; Maeno T; Fujita Y; Kurabayashi M; Ikeda Y
Intern Med; 2015; 54(23):3057-60. PubMed ID: 26631892
[TBL] [Abstract][Full Text] [Related]
17. Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer - study protocol of the FORCE trial.
Bozorgmehr F; Hommertgen A; Krisam J; Lasitschka F; Kuon J; Maenz M; Huber PE; König L; Kieser M; Debus J; Thomas M; Rieken S
BMC Cancer; 2019 Nov; 19(1):1074. PubMed ID: 31703637
[TBL] [Abstract][Full Text] [Related]
18. A prospective open-label study of sirolimus for the treatment of anti-Hu associated paraneoplastic neurological syndromes.
de Jongste AH; van Gelder T; Bromberg JE; de Graaf MT; Gratama JW; Schreurs MW; Hooijkaas H; Sillevis Smitt PA
Neuro Oncol; 2015 Jan; 17(1):145-50. PubMed ID: 24994790
[TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy treatment for anti-Hu paraneoplastic syndrome without active malignancy].
Gaillard N; Charif M; Carlander B; Pujol JL; Touchon J
Rev Neurol (Paris); 2006 Sep; 162(8-9):862-5. PubMed ID: 17028549
[TBL] [Abstract][Full Text] [Related]
20. Improvement of anti-Hu-associated paraneoplastic sensory neuropathy after chemoradiotherapy in a small cell lung cancer patient.
Suzuki M; Kimura H; Tachibana I; Fujimura H; Nakatsuji Y; Sugai F; Naba I; Nakamori M; Morishita H; Arai T; Osaki T; Hayashi S
Intern Med; 2001 Nov; 40(11):1140-3. PubMed ID: 11757772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
